With so many exciting chronic lymphocytic leukemia (CLL) trials ongoing, the data to be presented at the upcoming American Society of Hematology (ASH) 2018 Annual Meeting and Exposition is highly anticipated. We spoke to Stephan Stilgenbauer, MD, of the University of Ulm, Ulm, Germany, about the trials to watch out for at ASH 2018, including CLL14 (NCT02242942), iLLUMINATE (NCT02264574) and ALLIANCE A041202 (NCT01886872). This interview took place at the European Research Initiative on CLL (ERIC) International Meeting 2018, held in Barcelona, Spain.

свернуть